Speaker
President & Chief Executive Officer, Cascade Biotechnology
Daniel Benjamin, President & Chief Executive Officer at Cascade Biotechnology, is speaking at 10th Complement-Based Drug Development Summit (Boston, United States of America, 8–10 Dec 2026) in the session “Identifying Novel Complement Targets & Accurately Measuring Target Engagement to Guide Therapeutic Design, Facilitate Differentiation & Improve Clinical Outcomes”.
8–10 Dec 2026Boston, United States of America
Senior Vice President, Research, Graviton BioSciences
Senior Director, Immunology, Seismic Therapeutics
Chief Executive Officer, Ikarovec
Principal Scientist, Sanofi
Chief Development Advisor, NeuParadigm Bio
Chief Scientific Officer, Complement Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Daniel Benjamin, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].